Ibrutinib Contributes to Atrial Arrhythmia through the Autophagic Degradation of Connexins by Inhibiting the PI3K-AKT-mTOR Signaling Pathway
Frontiers in Bioscience-Landmark · 2024
DOI: 10.31083/j.fbl2905201 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, 2024. Verfasst von Huiyuan Qin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 211166 Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Adenine, TOR Serine-Threonine Kinases, Autophagy, Proto-Oncogene Proteins c-akt. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Nature Science Foundation of China.
Abstract (Originalsprache)
Background
Ibrutinib could increase the risk of atrial fibrillation (AF) in chronic lymphocytic leukemia (CLL) patients. However, the precise mechanism underlying ibrutinib-induced AF remains incompletely elucidated.
Methods
We investigated the proportion of ibrutinib-treated CLL patients with new-onset AF. Optical mapping was conducted to reveal the proarrhythmic effect of ibrutinib on HL-1 cells. Fluorescence staining and western blot were used to compare connexins 43 and 40 expression in ibrutinib-treated and control groups. To identify autophagy phenotypes, we used western blot to detect autophagy-related proteins, transmission electron microscopy to picture autophagosomes, and transfected mCherry-GFP-LC3 virus to label autophagosomes and lysosomes. Hydroxychloroquine as an autophagy inhibitor was administered to rescue ibrutinib-induced Cx43 and Cx40 degradation.
Results
About 2.67% of patients developed atrial arrhythmias after ibrutinib administration. HL-1 cells treated with ibrutinib exhibited diminished conduction velocity and a higher incidence of reentry-like arrhythmias compared to controls. Cx43 and Cx40 expression reduced along with autophagy markers increased in HL-1 cells treated with ibrutinib. Inhibiting autophagy upregulated Cx43 and Cx40.
Conclusions
The off-target effect of ibrutinib on the PI3K-AKT-mTOR signaling pathway caused connexin degradation and atrial arrhythmia via promoting autophagy. Clinical Trial Registration: ChiCTR2100046062, https://clin.larvol.com/trial-detail/ChiCTR2100046062.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiology, The First Affiliated Hospital of Nanjing Medical University, 211166 Nanjing, Jiangsu, China.
- Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, 211166 Nanjing, Jiangsu, China.
- Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, 211166 Nanjing, Jiangsu, China.
Förderung
- National Nature Science Foundation of China
Zitieren
APA
Qin, H., Zheng, B., Lin, Z., Ji, Y., Wang, C., Zhu, H., Cui, C., Wang, Z., & Chen, M. (2024). Ibrutinib Contributes to Atrial Arrhythmia through the Autophagic Degradation of Connexins by Inhibiting the PI3K-AKT-mTOR Signaling Pathway. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/j.fbl2905201
Vancouver
Qin H, Zheng B, Lin Z, Ji Y, Wang C, Zhu H, et al. Ibrutinib Contributes to Atrial Arrhythmia through the Autophagic Degradation of Connexins by Inhibiting the PI3K-AKT-mTOR Signaling Pathway. Frontiers in Bioscience-Landmark. 2024. doi:10.31083/j.fbl2905201
BibTeX
@article{Qin2024,
author = {Qin, Huiyuan and Zheng, Bingyu and Lin, Zhiqiao and Ji, Yumeng and Wang, Cheng and Zhu, Huayuan and Cui, Chang and Wang, Zidun and Chen, Minglong},
title = {Ibrutinib Contributes to Atrial Arrhythmia through the Autophagic Degradation of Connexins by Inhibiting the PI3K-AKT-mTOR Signaling Pathway},
journal = {Frontiers in Bioscience-Landmark},
year = {2024},
doi = {10.31083/j.fbl2905201}
}
EUVIMED